•  
  •  
  •  
  •  

2025-12-23 10:20:59

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  LandT

Research

  • L&T Technology Services - Institutional Research Desk at HDFC Securities
  • L&T Technology Services - Q3FY23 Result Update - YES Securities
  • L&T Finance Holdings Ltd - Not Rated - Q3 FY23 Call Takeaways - YES Securities
  • Maintain ADD on L&T Technology Services - Good show - HDFC Securities
  • L&T Technology Services - Unfavourable risk-reward, expensive valuations - ICICI Securities
  • L&T Technology Services - Q4FY22 Result Update - Fundamentals intact, expensive valuations - Downgrade to 'ACCUMULATE'
  • L&T Technology Services - Result Report Q3 FY22 - YES Securities
  • L&T Technology Services - Overall, performance was ahead of expectations - YES Securities
  • L&T Technology Services - ER&D leadership shines through - HDFC Securities

Stock Report

  • Bigbloc Construction Ltd secures order from L&T Construction
  • L&T Technology Services, PALFINGER Inaugurate GDC as Part of Multi-Year Engagement to Accelerate Product Development
  • Emerald Finance Ltd partners with Interactive Financial and Trading Services Pvt Ltd
  • L&T Technology Services Transforms Respiratory Diagnostics with NVIDIA AI-Powered Digital Twin Technology
  • Larsen & Toubro and BAE Systems secure Indian Army licensed manufacturing contract for BvS10
  • L&T Technology Services, Autodesk Partner to Drive Digital Transformation in Process and Manufacturing Industries
  • L&T-BEL's 5th Gen Fighter Aircraft Alliance onboards Dynamatic Technologies as Exclusive Partner
  • L&T and GA-ASI Announce Strategic Partnership for MALE RPAS Manufacture in India
  • L&T secures a key role in TenneT''s landmark offshore Wind Program
  • L&T Heavy Engineering wins Orders in India and Abroad
  • L&T wins large orders for Minerals & Metals Business
  • L&T Technology Services Recertification at Caterpillar's Supplier Excellence Recognition Event for Second Consecutive Year
  • L&T Technology Services Ltd declares interim dividend of Rs. 18
  • L&T Technology Services Limited Q2 FY2025-26 consolidated net profit increases to Rs. 328.7 crores
  • L and T Finance Ltd reports consolidated net profit of Rs. 734.84 crores in Q2 FY2026
  • SEAMEC Ltd enters into Bimco Charter Party with L&T
  • Ultracab India Ltd receives annual rate contract from L&T Construction
  • CP PLUS Partners with L&T Semiconductor for Next-Gen IP Cameras
  • L&T wins Ultra-Mega Order for Hydrocarbon Onshore Business
  • L&T wins major orders in India for Building & Factories Business
  • L&T Technology Services wins USD 100 Million Multi-Year Program from US-Based Industrial Equipment Manufacturer
  • L&T Secures USD 700 mn Sustainability Linked Trade Facility with Standard Chartered
  • L&T Technology Services, Siemens Partner for AI-led Transformation in Process Engineering & Smart Manufacturing
  • L&T forms Strategic Partnership with BEL for India's 5th-Generation Fighter Aircraft Programme

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024